News » Archives » August 2018

Biophysicist awarded $1.1 million NIH grant to study role of protein dynamics in antibiotic resistance

Author: Cheryl Schairer

Jeff W. Peng

The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe.  Results from the research of Jeff W. Peng, associate professor of chemistry and biochemistry, could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.

Read More

What makes a good malaria vector?

Author: Carin Moonin

Besansky 250

Nora J. Besansky, the O'Hara Professor and Associate Chair in the Department of Biological Sciences, hypothesizes in a recent paper in the Proceedings of the National Academy of Sciences that if scientists can understand what makes a small group of Anopheles mosquito a strong malaria vector, then perhaps we can prevent the spread of disease.

Read More

Direct coupling of the Higgs boson to the bottom quark observed

Author: Colin Jessop, Ph.D.

High Energy Physics Group: Mitch Wayne, Kevin Lannon, Colin Jessup, Randy Ruchti, and Mike Hildreth

An observation made by the Compact Muon Solenoid (CMS) experiment at CERN represents yet another important milestone reached in the scrutiny of the Higgs boson and its interactions with Standard Model particles. Members of the Notre Dame CMS group include Professors Michael Hildreth, Colin Jessop, Kevin Lannon, Nancy Marinelli, Randal Ruchti and Mitchell Wayne of the Department of Physics are all members of the CMS collaboration.

 

Read More

Notre Dame Science of Wellness Initiative announces new Catalyst Seed Grant Program

Author: Brandi Klingerman

 

Main Building

Notre Dame’s Science of Wellness Initiative (SWI), which is an initiative of the Provost’s Office, has announced the new Catalyst Seed Grant (CSG) Program. Full-time, regular Notre Dame faculty from all disciplines are encouraged to apply. The CSG Program will provide funding to researchers to explore creative and diverse research opportunities in the science of wellness that have strong and near-term potential to develop into larger, externally funded research programs.

Read More

Notre Dame Startup Structured Immunity and Medigene Announce Collaboration Aimed at Improving T Cell Receptor Development

Author: Nick Swisher

Brian Baker 250

Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene’s TCR discovery activities.

Read More

Notre Dame Environmental Change Initiative welcomes new postdoctoral scholars

Author: Brandi Klingerman

Dome With Clouds

Five postdoctoral research associates have joined the University of Notre Dame’s Environmental Change Initiative (ND-ECI). The researchers will contribute to several research programs, including the Notre Dame Global Adaptation Initiative (ND-GAIN), and collaborate with ECI-affiliated faculty.

Read More

Developing an “on and off” switch for breast cancer treatment

Author: Brandi Klingerman

Golden Dome and Basilica across St. Joseph's Lake

A current cancer therapy is using T-cells and genetically engineering them to kill cancer, but these cells, known as CAR-T cells, have been known to attack off-target sites while completing their job. In order to counteract this negative effect, Notre Dame researchers are working to create nanoparticles that act as an “on and off” switch to improve the safety and effectiveness of this cancer therapy.

Read More

Growth in Notre Dame research and scholarship funding continues

Author: Brandi Klingerman

Researchfunding 250

The University of Notre Dame continued the steady expansion and growth of its research, scholarship, and creative endeavor programs during the most recent fiscal year (FY), recording $141.6 million in research funding. This surpasses the $138.1 million received in FY 2017. The amount is part of a trend that has led to a 75 percent increase in external research funding awarded to Notre Dame compared to 10 years ago. 

Read More

Baker honored by the American Cancer Society’s Coaches vs. Cancer program

Author: Brandi Klingerman

Brian Baker 250

Brian Baker, Rev. John A. Zahm Professor of Structural Biology at the University of Notre Dame, has received the Innovation Award from the American Cancer Society’s (ACS) local Coaches vs. Cancer program. The Innovation Award is described as being given to “an individual who demonstrates an innovative approach to treating or caring for cancer patients and their loved ones.”

Read More